THRESHOLD PHARMACEUTICALS INC

THRESHOLD PHARMACEUTICALS INC insiders are currently net sellers of THLD stock, showing bearish sentiment over the past 90 days. Total sales of $188.3M outpace purchases of $21.5M, creating a net outflow of $166.8M.

THRESHOLD PHARMACEUTICALS INC has 31 active insiders who have filed SEC Form 4 transactions in the past 90 days. Vi, L.p. Fhm (Executive) leads with 6 transactions totaling $80.7M. Wilfred E. Jaeger (Executive) follows with 65 transactions worth $39.8M. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. THRESHOLD PHARMACEUTICALS INC's current score of 10/100 indicates bearish insider sentiment. Scores below 40 indicate selling pressure exceeds buying. Insider selling often reflects diversification needs, tax optimization, or estate planning.

The most recent insider transaction occurred on Jun 1, 2017, when W. Bird Jeffrey (Executive) acquired 473,077 shares at $0.57 per share for $269.7K. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, THLD insider trading sentiment is currently bearish with an Alignment Score of 10/100. The negative net flow of $166.8M shows more selling than buying. However, 0% of recent transactions are 10b5-1 scheduled trades.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like THRESHOLD PHARMACEUTICALS INC. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At THLD, we track all Form 4 filings—currently showing 381 transactions from 31 insiders over 90 days.

A 10b5-1 plan allows THRESHOLD PHARMACEUTICALS INC executives to pre-schedule stock sales when they don't possess material non-public information. At THLD, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at THLD appears discretionary, making insider signals more meaningful.

You can monitor THRESHOLD PHARMACEUTICALS INC (THLD) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 31 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. THRESHOLD PHARMACEUTICALS INC's current score of 10/100 indicates bearish sentiment with significant insider selling pressure. This is calculated from $21.5M in purchases versus $188.3M in sales over 90 days, resulting in a net flow of -$166.8M.

SEC Form 4 filings are mandatory reports that THRESHOLD PHARMACEUTICALS INC insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At THLD, the most common type is "X" with 20 occurrences. The most recent Form 4 was filed on Jun 1, 2017 by W. Bird Jeffrey.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At THRESHOLD PHARMACEUTICALS INC, approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at THLD represents discretionary decisions with more informational value.